United Therapeutics Corporation Authorizes Additional $2 Billion for Share Repurchase Program

United Therapeutics Corporation (NASDAQ: UTHR) announced an additional authorization of up to $2 billion for the repurchase of its common stock. This new authorization is in addition to the approximately $1.2 billion remaining under its previous share repurchase program. The company may execute repurchases through various methods, including accelerated share repurchase programs and open market transactions.